Ying Tan

2.6k citations
88 papers · 1.7k indexed · h-index 22
Topics
Renal Diseases and Glomerulopathies (39 papers)Systemic Lupus Erythematosus Research (39 papers)Complement system in diseases (17 papers)
Journals
ScienceJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Ying Tan

82 papers receiving 1.7k citations

Peers

Ying Tan
Comparison fields: 5 of 94
  • Rheumatology 863
  • Nephrology 788
  • Immunology 785
  • Radiology, Nuclear Medicine and Imaging 298
  • Molecular Biology 249
Replace Tsukasa Takemura with:
Tsukasa Takemura Japan
Shizuyo Tsujimura Japan
Abraham Rutgers Netherlands
Thomas Rauen Germany
Joshua D. Ooi Australia
Andrew W. Minto United States
Frank Bienaimé France
Yasushi Nakamoto Japan
Irene Cecchi Italy
Brandon Renner United States
Ying Tan relative to Tsukasa Takemura Japan Tsukasa Takemura's profile →
Citations per field
00.5×9.7×
Tsukasa Takemura · 1×
Citations per year

Countries citing papers authored by Ying Tan

Since Specialization
Citations

This map shows the geographic impact of Ying Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Tan more than expected).

Fields of papers citing papers by Ying Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Tan. The network helps show where Ying Tan may publish in the future.

Co-authorship network of co-authors of Ying Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Tan. A scholar is included among the top collaborators of Ying Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Tan. Ying Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 2
4 0
5 0
6 13
7 11
8 1
9 9
10 7
11 3
12 21
13 5
14 30
15 21
16 12
17 112
18
Subconjuctival Administration of Endostatin Improves Corneal Allograft Survival
1
19 50
20 47

About Ying Tan

Ying Tan is a scholar working on Nephrology, Rheumatology and Immunology, having authored 88 papers that have together received 1.7k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (39 papers), Systemic Lupus Erythematosus Research (39 papers) and Complement system in diseases (17 papers). The work is most often cited by research in Nephrology (788 citations), Rheumatology (863 citations) and Immunology (785 citations). Ying Tan has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Feng Yu, Ming‐Hui Zhao, Suxia Wang, Lihua Wu, M-H Zhao, Zhen Qu, Menghua Chen, Gang Liu, Wan-zhong Zou and Fan Yu. Their work appears in journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026